FC-RECEPTOR FOR MOUSE IGG1 (FC-GAMMA-RII) AND ANTIBODY-MEDIATED CELL CLEARANCE IN PATIENTS TREATED WITH LEU2A ANTIBODY

被引：31

作者：

WEE, SL

COLVIN, RB

PHELAN, JM

PREFFER, FI

REICHERT, TA

BERD, D

COSIMI, AB

机构：

[1] MASSACHUSETTS GEN HOSP,DEPT PATHOL,IMMUNOPATHOL UNIT,BOSTON,MA 02114

[2] MASSACHUSETTS GEN HOSP,GEN SURG SERV,TRANSPLANTAT IMMUNOL UNIT,BOSTON,MA 02114

[3] THOMAS JEFFERSON UNIV,DEPT MED,DIV ONCOL,PHILADELPHIA,PA 19107

[4] HARVARD UNIV,SCH MED,BOSTON,MA 02115

[5] BECTON DICKINSON IMMUNOCYTOMETRY SYST,MT VIEW,CA 94039

来源：

TRANSPLANTATION | 1989年 / 48卷 / 06期

关键词：

D O I：

10.1097/00007890-198912000-00024

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1012 / 1017

页数：6

共 32 条

[1]

ADO TAB, 1984, J EXP MED, V160, P303

[2]

ANDERSON CL, 1987, J IMMUNOL, V138, P2254

[3] PREVENTION OF ALLOANTIBODY FORMATION AFTER SKIN-GRAFTING WITHOUT PROLONGATION OF GRAFT-SURVIVAL BY ANTI-L3T4 INVIVO [J].

AUCHINCLOSS, H ;

GHOBRIAL, RRM ;

RUSSELL, PS ;

WINN, HJ .

TRANSPLANTATION, 1988, 45 (06) :1118-1123

[4] TOLERANCE TO RAT MONOCLONAL-ANTIBODIES - IMPLICATIONS FOR SEROTHERAPY [J].

BENJAMIN, RJ ;

COBBOLD, SP ;

CLARK, MR ;

WALDMANN, H .

JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) :1539-1552

[5]

BERD D, 1987, CANCER RES, V47, P2727

[6]

CEUPPENS JL, 1987, J IMMUNOL, V139, P4067

[7]

CEUPPENS JL, 1985, J IMMUNOL, V135, P3882

[8] HOW IMPORTANT IS THE L3T4 ANTIGEN TO L3T4+ CELL-FUNCTION INVIVO [J].

CHARLTON, B ;

BURKHARDT, K ;

MANDEL, TE .

IMMUNOLOGY TODAY, 1988, 9 (06) :165-167

[9] THERAPY WITH MONOCLONAL-ANTIBODIES BY ELIMINATION OF T-CELL SUBSETS INVIVO [J].

COBBOLD, SP ;

JAYASURIYA, A ;

NASH, A ;

PROSPERO, TD ;

WALDMANN, H .

NATURE, 1984, 312 (5994) :548-551

[10] USE OF MONOCLONAL-ANTIBODIES TO T-CELL SUBSETS FOR IMMUNOLOGICAL MONITORING AND TREATMENT IN RECIPIENTS OF RENAL-ALLOGRAFTS [J].

COSIMI, AB ;

COLVIN, RB ;

BURTON, RC ;

RUBIN, RH ;

GOLDSTEIN, G ;

KUNG, PC ;

HANSEN, WP ;

DELMONICO, FL ;

RUSSELL, PS .

NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (06) :308-314

← 1 2 3 4 →